New York, NY -- (SBWIRE) -- 01/09/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Extreme Networks, Inc (NASDAQ:EXTR), OraSure Technologies, Inc (NASDAQ:OSUR), TTM Technologies, Inc (NASDAQ:TTMI), Sequenom, Inc (NASDAQ:SQNM)
Extreme Networks, Inc (NASDAQ:EXTR) showed a volume of 1.20 million shares by the end of last trade whereas the average volume of the stock remained 1.19 million shares. The stock opened the session at $6.82 but then moved to $7.17. At that price, the stock showed a positive performance of 3.46%. Extreme Networks, Inc. together with its subsidiaries, is a provider of network infrastructure equipment and services for enterprises, data centers, and service providers. The Company’s customers include businesses, hospitals, schools, hotels, telecommunications companies and government agencies globally. The Company sells its products through an ecosystem of the Company channel partners who combine its Ethernet products with their offerings to create compelling information technology solutions for end user customers.
Will EXTR Continue To Move Higher? Find Out Here
OraSure Technologies, Inc (NASDAQ:OSUR) opened the session at $6.59 and closed the session at $6.98. The stock showed a positive performance of 5.44% in previous trading session. Traded with volume of 1.18 million shares in the prior session and the average volume of the stock remained 774,028.00 shares. OraSure Technologies, Inc., is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using the Company's oral fluid technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The Company's diagnostic products include tests that are performed on a rapid basis at the point of care and tests that are processed in a laboratory.
For How Long OSUR will fight for Profitability? Read This Trend Analysis report
TTM Technologies, Inc (NASDAQ:TTMI) opened the session at $8.39 and closed the session at $8.41. The stock showed a negative performance of -0.12% in previous trading session. Traded with volume of 1.16 million shares in the prior session and the average volume of the stock remained 707,957.00 shares. The beta of the stock remained 1.56. TTM Technologies, Inc. (TTM) is a provider of time-critical and technologically complex printed circuit board (PCB) products and backplane assemblies (PCBs populated with electronic components), which serves as the foundation of sophisticated electronic products. It focuses on providing time-to-market and advanced technology products and offer a one-stop manufacturing solution to its stomers from engineering support to prototype development through final volume production. This one-stop solution allows them to align technology development with the diversified needs of its customers, many of whom are based in high growth markets, and to enable them to reduce the time required to develop new products and bring them to market.
Why Should Investors Buy TTMI After the Recent Fall? Just Go Here and Find Out
Sequenom, Inc (NASDAQ:SQNM) the stock advanced 1.23% and finished the session at $2.46. Traded with volume of 1.52 million shares in the prior session and the average volume of the stock remained 1.72 million shares. The beta of the stock remained 0.40. Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research. The Company’s development and commercialization efforts in various diagnostic areas include noninvasive women’s health-related and prenatal diagnostics,
Will SQNM Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)